Portal de Periódicos da CAPES

A novel mutation in the proteoglycan 4 gene causing CACP syndrome: two sisters report

2023; BioMed Central; Volume: 21; Issue: 1 Linguagem: Inglês

10.1186/s12969-023-00793-z

1546-0096

İlknur Bağrul, Serdar Ceylaner, Yasemin Taşçı Yıldız, Serife Tuncez, Elif Arslanoğlu Aydın, Esra Bağlan, Semanur Özdel, Mehmet Bülbül,

Neonatal Respiratory Health Research

Camptodactyly-arthropathy-coxa vara-pericarditis (CACP) syndrome, caused by biallelic pathogenic mutations in the proteoglycan 4 (PRG4) gene, is characterized by early-onset camptodactyly, noninflammatory arthropathy, coxa vara deformity, and rarely, pericardial effusion. This syndrome can mimic juvenile idiopathic arthritis. CACP syndrome is caused by mutations in the proteoglycan 4 (PRG4) gene. To date, only 36 pathogenic mutations have been reported in this gene, but none have been reported from Azerbaijan.Herein, we report two siblings presented with chronic polyarthritis, had a prior diagnosis of juvenile idiopathic arthritis, but was subsequently diagnosed as CACP syndrome with novel mutation in the PRG4 gene.Our report expands the knowledge of PRG4 mutations, which will aid in CACP patient counseling.